What is ADCT stock price today?

Visit our real-time dashboard for the current ADCT stock price and live market data.

Is ADCT stock going up or down today?

ADCT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADCT stock now?

The decision to buy ADCT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADCT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADCT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADCT stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADCT is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADCT's P/E ratio?

P/E ratio data for ADCT will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADCT's market cap?

ADCT (ADC Therapeutics SA) has a market capitalization of $0.14 billion, making it a small-cap stock.

What is ADCT's price to book ratio?

ADCT trades at a price-to-book (P/B) ratio of 3.42, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ADCT pay dividends?

ADCT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADCT's dividend yield?

ADCT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADCT stock a good long-term investment?

ADCT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADCT's revenue growth rate?

Revenue growth data for ADCT is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADCT are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADCT?

Key risks for ADCT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADCT compare to its competitors?

Compare ADCT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADCT's performance and positioning.

What is ADCT's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADCT with bull, base, and bear case scenarios.

What do analysts say about ADCT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADCT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADCT's next earnings report?

ADCT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADCT - ADC Therapeutics SA

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About ADC Therapeutics SA

ADC Therapeutics SA (ADCT) common stock

Price Chart

Loading chart...

ADCT Key Statistics

Market Cap

$141.18M

P/B Ratio

3.42

How ADCT Compares to Peers

ADCT is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADCT(This stock)	$141.18M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 2:05 PM EDT

Ready to invest in ADCT?

Commission-free trading available. Affiliate links.

ADCT Lician Score

10% confidence

5.0/10

Neutral

ADCT has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ADCTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ADCT Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ADCT

Dashboard

Enter a ticker to analyze